Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Epizyme, Inc. | 106,344 | reported | 09 Feb 2018 | tx 3+394,852 |
| Aardvark Therapeutics, Inc. | 30,508 | reported | 11 Jun 2025 | tx 1+30,508 |
| CG Oncology, Inc. | 24,165 | reported | 05 Jun 2025 | tx 2+39,765 |
| Finch Therapeutics Group, Inc. | 5,010 | reported | 09 Jun 2023 | tx 4+83,272 |
| NPS PHARMACEUTICALS INC | 0 | reported | 21 Feb 2015 | tx 20+106,426−106,426 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2025 | GRANT_AWARD | Aardvark Therapeutics, Inc. | 30,508 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | CG Oncology, Inc. | 24,165 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | CG Oncology, Inc. | 15,600 | 0.00 USD | deriv |
| 09 Jun 2023 | PURCHASE | Finch Therapeutics Group, Inc. | 5,010 | 0.27 USD | |
| 08 Jun 2023 | GRANT_AWARD | Finch Therapeutics Group, Inc. | 10,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Finch Therapeutics Group, Inc. | 44,843 | 0.00 USD | deriv |
| 23 Apr 2021 | GRANT_AWARD | Finch Therapeutics Group, Inc. | 23,419 | 0.00 USD | deriv |
| 09 Feb 2018 | GRANT_AWARD | Epizyme, Inc. | 106,344 | 0.00 USD | deriv |
| 08 Feb 2017 | GRANT_AWARD | Epizyme, Inc. | 109,866 | 0.00 USD | deriv |
| 25 Apr 2016 | GRANT_AWARD | Epizyme, Inc. | 178,642 | 0.00 USD | deriv |
| 21 Feb 2015 | TENDER | NPS PHARMACEUTICALS INC | 4,761 | 46.00 USD | |
| 21 Feb 2015 | OTHER | NPS PHARMACEUTICALS INC | 10,905 | — | deriv |
| 21 Feb 2015 | OTHER | NPS PHARMACEUTICALS INC | 2,893 | — | deriv |
| 21 Feb 2015 | OTHER | NPS PHARMACEUTICALS INC | 11,577 | — | deriv |
| 21 Feb 2015 | OTHER | NPS PHARMACEUTICALS INC | 41,289 | — | deriv |
| 21 Feb 2015 | OTHER | NPS PHARMACEUTICALS INC | 11,874 | — | deriv |
| 12 Feb 2015 | EXERCISE | NPS PHARMACEUTICALS INC | 1,445 | — | |
| 12 Feb 2015 | TAX_WITHHOLDING | NPS PHARMACEUTICALS INC | 484 | 45.85 USD | |
| 12 Feb 2015 | GRANT_AWARD | NPS PHARMACEUTICALS INC | 10,905 | 0.00 USD | deriv |
| 12 Feb 2015 | EXERCISE | NPS PHARMACEUTICALS INC | 1,445 | 0.00 USD | deriv |
| 10 Feb 2015 | EXERCISE | NPS PHARMACEUTICALS INC | 6,711 | 14.90 USD | |
| 10 Feb 2015 | SALE | NPS PHARMACEUTICALS INC | 6,711 | 45.87 USD | |
| 10 Feb 2015 | EXERCISE | NPS PHARMACEUTICALS INC | 6,711 | 0.00 USD | deriv |
| 17 Jun 2014 | TAX_WITHHOLDING | NPS PHARMACEUTICALS INC | 1,988 | 33.10 USD | |
| 17 Jun 2014 | EXERCISE | NPS PHARMACEUTICALS INC | 5,788 | — |